Search
Search
| Catalog Number | Quantity | Packaging |
|---|---|---|
| 215390050 | 5g | Glass bottle |
General Description
• Epiandrosterone is a steroid hormone, derived from 5 α-androstane
• It is a dehydroepiandrosterone metabolite and an androgen
• It is a precursor of testosterone and estradiol with hypolipidemic and anabolic activities
Applications
• Epiandrosterone presents some neurological activity since it can bind to the ɣ-aminobutyric acid (GABA)/benzodiazepine-receptor complex (GABA-RC), acting as a negative non-competitive modulator of GABA-RC, and signaling through the N-methyl-D-aspartate receptor
• It can also inhibit the pentose phosphate pathway, dilating blood vessels pre-contracted by partial depolarization
• Epiandrosterone can inhibit the thromboxane A2 synthesis in activated platelets, decrease plasma plasminogen activator inhibitor type 1, reduce tissue plasminogen activator antigen, improve insulin-like growth factor 1 serum levels, and increase the synthesis of cyclic guanosine monophosphate and nitric oxide
• In vitro assays demonstrate that this compound inhibits Junin virus replication vitro anti-adenovirus (AdV) activity
• Epiandrosterone affects glucose oxidation and interleukin-1 beta in in vitro pancreatic islets
Literature References
Nair, V.; Doman, C.; Morrison, M.; Miller, G.; Husk, J.; Eenoo, P.; Crouch, A.; Eichner, D. Evaluation of epiandrosterone as a long-term marker of testosterone use. Drug Test Anal. 2020, 12 (11-12), 1554-1560.
Acosta, E.G.; Bruttomesso, A.C.; Bisceglia, J.A.; Wachsman, M.B.; Galagovsky, L.R.; Castilla, V. Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro. Virus Res. 2008, 135, (2), 203-212.
Romanutti, C.; Bruttomesso, A.C., Castilla, V.; Galagovsky, L.R.; Wachsman, M.B. Anti-adenovirus activity of epiandrosterone and dehydroepiandrosterone derivatives. Chemotherapy. 2010, 56, (2), 158-65. Laychock, S.G.; Bauer, A.L. Epiandrosterone and dehydroepiandrosterone affect glucose oxidation and interleukin-1 beta effects in pancreatic islets. Endocrinology. 1996, 137, (8), 3375-3385.